Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Hirudoid on Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A - A Real-World Multicenter, Prospective, Interventional Study

NCT07388927 is registered in ClinicalTrials.gov with DKSH Management (Thailand) Limited as lead sponsor.

NCT NCT07388927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07388927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Hirudoid on Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A - A Real-World Multicenter, Prospective, Interventional Study
Lead sponsor
DKSH Management (Thailand) Limited
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
April 30, 2026
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crow's feet lines, ecchymosis after periorbital rejuvenation with botulinum toxin type a, lateral canthal lines, lcl